Close

Immunogen, Inc. (IMGN) Reports Q4 EPS Loss of $0.23

August 3, 2011 4:29 PM EDT
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $4.41 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings